NCT00277056|TerminatedDMC
Study Stopped
This is not a clinical trial and was entered in the system in error.
Loading search results
Sponsor study identifier
observational
30
1 country
1
Study Start
May 2002
Actual (reported)Primary Completion
October 2005
Actual (reported)Study Completion
October 2005
Actual (reported)Dysregulated Tyrosine Kinase Signaling in Leukemia
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2005
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2002
Actual (reported)October 2005
Actual (reported)October 2005
Actual (reported)January 11, 2006
Actual (reported)January 13, 2006
Actual (reported)people with leukemia
Contact the study team to confirm eligibility.
University of New Mexico
Albuquerque, New Mexico, 87131, United States
blood bone marrow
Ian Rabinowitz, MD
University of New Mexico
30 participants (actual enrollment reported by the registry).
First Submitted
January 11, 2006
First Posted
January 13, 2006
Study Start
May 2002
Actual (reported)STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia
Primary Completion
October 2005
Actual (reported)Study Completion
October 2005
Actual (reported)Last Updated
February 7, 2024
Record last verified: 2024-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: